Pricing
  1. US-listed companies
  2. SELLAS Life Sciences Group, Inc.
  3. Financials
  4. Net income

SELLAS Life Sciences Group, Inc. (SLS)

Market cap
$552.77M
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2024-31-17.21%
Dec 31, 2023-37-9.69%
Dec 31, 2022-41+99.52%
Dec 31, 2021-21+23.21%
Dec 31, 2020-17-12.92%
Dec 31, 2019-19-30.28%
Dec 31, 2018-28+16.49%
Dec 31, 2017-24+0.87%
Dec 31, 2016-24-63.15%
Dec 31, 2015-64+74.57%
Dec 31, 2014-37-52.26%
Dec 31, 2013-77

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat